GlassScriptPhysician profile
Gena Lee Thompson
NPI 1811212392
$13,070.46
in general payments reported to CMS, 2019-2025
43 companies · $4,339 in 2025
The $4,339 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $384 · 2022: $3,230 · 2023: $2,505 · 2024: $2,613 · 2025: $4,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,219 · Travel and Lodging: $1,140 · Education: $97.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,219.07 |
| Travel and Lodging | $1,140.03 |
| Education | $97.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,373.88 | 2021-2025 | |
| Enterra Medical, INC. | $1,600.14 | 2025 | |
| Janssen Biotech, INC. | $1,089.49 | 2022-2025 | Stelara, Tremfya, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $904.01 | 2022-2025 | Xifaxan, Trulance, Relistor |
| Takeda Pharmaceuticals U.S.A., INC. | $786.97 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Regeneron Healthcare Solutions, INC. | $451.47 | 2022-2025 | Dupixent |
| Aimmune Therapeutics, INC. | $382.41 | 2024-2025 | Zenpep |
| Celltrion USA INC. | $367.57 | 2024-2025 | Vegzelma, Zymfentra |
| Redhill Biopharma INC. | $359.64 | 2022-2023 | Talicia, Aemcolo, Movantik |
| Gilead Sciences, INC. | $336.09 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $322.88 | 2022 | |
| Merck Sharp & Dohme LLC | $238.93 | 2022-2024 | Dificid |
| Madrigal Pharmaceuticals | $233.76 | 2024-2025 | Rezdiffra, Resmetirom |
| Pfizer INC. | $220.75 | 2021-2025 | |
| Novo Nordisk INC | $188.43 | 2025 | Wegovy |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $182.62 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $178.23 | 2024-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $178.03 | 2022-2023 | |
| Intercept Pharmaceuticals, INC. | $156.29 | 2023 | Ocaliva |
| Ironwood Pharmaceuticals, INC | $155.06 | 2022-2024 | Linzess |
| Ardelyx, INC. | $154.49 | 2023-2025 | Ibsrela |
| Lilly USA, LLC | $151.12 | 2024-2025 | Omvoh |
| Celgene Corporation | $145.38 | 2022-2024 | Zeposia |
| Ferring Pharmaceuticals INC. | $115.01 | 2022-2023 | Rebyota |
| Daiichi Sankyo INC. | $107.49 | 2023-2024 | Injectafer |
| Evoke Pharma, INC. | $105.37 | 2023-2025 | Gimoti |
| Ipsen Biopharmaceuticals, INC | $74.21 | 2024-2025 | Iqirvo, Bylvay |
| Qol Medical, LLC | $63.54 | 2025 | Sucraid |
| Braintree Laboratories, INC. | $61.58 | 2022-2023 | Sutab |
| Exact Sciences Corporation | $58.49 | 2023-2024 | Cologuard Collection Kit |
| Organon LLC | $53.95 | 2023-2025 | Hadlima, Renflexis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.19 | 2024 | Cyltezo |
| Endogastric Solutions, INC | $30.24 | 2022-2023 | Esophyx |
| Intra-Sana Laboratories | $28.95 | 2022-2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Alnylam Pharmaceuticals INC. | $24.94 | 2025 | Givlaari |
| Fresenius Kabi USA, LLC | $22.01 | 2023 | Idacio |
| Nestle Healthcare Nutrition INC. | $20.83 | 2022 | |
| Ambu INC. | $19.49 | 2023 | |
| Boston Scientific Corporation | $18.91 | 2022 | |
| Sandoz INC. | $18.51 | 2025 | Hyrimoz |
| Dentsply Ih Ab | $18.35 | 2024 | Navina Rectal Catheter Set Regular |
| Amgen INC. | $17.93 | 2022 | |
| Medtronic, INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gena Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.